Thanks to @tmarvan.bsky.social @magdalenamalecka.bsky.social for curating. Great to see on the program @mmilkowski.bsky.social @olesyabondarenko.bsky.social @danielkostic.bsky.social @malinowska.bsky.social @boruttrpin.bsky.social @apotochnik.bsky.social @elenapopaphi.bsky.social and many others

I’m so glad you found it interesting – it really means a lot ☺️

Thank you :)
I was actually going to write to you about this SI. I think you might find a few other articles interesting, as they address the use of racial categories in Germany:
freijournals.ub.uni-freiburg.de/behemoth/en/...

And here’s the abstract:

Full text:
freidok.uni-freiburg.de/files/271749...

The article appears in the special issue "National identities, biopolitics, and human diversity in contemporary European life sciences", edited by Andrea Zur Nieden, Nils Ellebrecht & Tino Plümecke and published in Behemoth ❤️

See the whole SI here:
freijournals.ub.uni-freiburg.de/behemoth/en/...

Why do drug labels keep reducing pharmacogenomic findings to just three groups: “White, Black, Asian”?

I explore why this is still happening. I also argue this practice has no epistemic value — and may mislead, posing real risks, e.g. for patients.

Thank you so much for your kind feedback on my talk! I hope we’ll have the chance to continue the discussion in person soon (and that I’ll finally manage to publish an article on this topic one day 😅)!

It was a really great symposium! Can't wait to read your papers :)

Absolutely! Just in case, I'll be on a short research residency at WICO Berlin from October 8-15 :)

Since the program is not yet online I am posting the screenshot of the panels from the newsletter. @mmilkowski.bsky.social @tmarvan.bsky.social @olesyabondarenko.bsky.social @apotochnik.bsky.social @magdalenamalecka.bsky.social @malinowska.bsky.social thank you for all the work!